In the Phase 2 trial, retatrutide was given as a once-weekly subcutaneous injection, starting at a low dose and escalating gradually up to 12 mg weekly
RDs typically help patients on GLP-1 medications focus on eating adequate protein, fiber, and micronutrients to prevent malnutrition and muscle loss
"Double the dose of these types of drugs is a massive difference it shows the market cannot be taken at face value," Mr Bonenti said
Being a part of the stage of drug development where a molecule gets tested in people for the first time struck me as something I wanted to be a part of
The inclusion of oral GLP-1s at $149/month could make these medications even more accessible for patients who prefer a pill over injections
While the science behind them may sound complex, their purpose is simple: helping your body respond to food in a healthier and more balanced way